Working out ABS: Preparing to Comply with the New EU Rules on Access and Benefit-sharing

Working out ABS image
  • Location: Paris, France
  • Date: 24/11/2014 - 25/11/2014
  • Event Type: Conference and workshops
  • Language: English

Interactive panel sessions, roundtable discussions and group exercises on how to implement the new ABS regulation. Companies and organizations using genetic resources in their R&D cannot afford to miss this event.

Pressure is on for any company or organization, accessing and utilizing genetic resources to comply with the recently adopted EU Regulation on Access and Benefit-sharing.

ICC is on hand to help you understand how the new Regulation will affect your internal operations and supply chains, what you will need to do to comply, and the legal and financial consequences of non-compliance.

Working with ABS experts from the European Commission, companies, and trade associations, participants will get: (a) an authoritative overview of the EU ABS rules including scope, compliance, user obligations, due diligence and sanctions, (b) a high-level platform from which to share best practices, challenges and experience, and (c) a unique opportunity to simulate compliance during learning-by-doing workshops.

    Who should attend?

    Anyone affected by the new EU ABS rules, particularly executives working in research and development, compliance, legal practice, supply chains, and sourcing in companies and organizations which manufacture, develop and/or distribute products based on genetic resources.

    Sectors include pharmaceutical, biotech, agricultural, cosmetics, fragrances, food and beverage, nutritional supplements, industrial enzymes, etc.

    Why ICC?

    ICC actively contributes to discussions on the links between intellectual property, genetic resources and traditional knowledge in several forums, including the Convention on Biological Diversity, the World Intellectual Property Organization and the World Trade Organization.

    Convention on Biological Diversity (CBD): Access and benefit sharing (ABS)

    The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (the Protocol) was concluded in October 2010 under the auspices of the CBD after many years of negotiations. This provides an international framework for establishing national regimes on ABS.

    ICC played an active role coordinating business participation in the negotiations and continues to coordinate business input in the process of national implementation of the Protocol.

    MONDAY 24 NOVEMBER AFTERNOON (14.00-19.00)

    Welcome address and introduction

    Overview of the new EU ABS Regulation

    Participants will gain insight into the main features of new EU ABS Regulation. European Commission speakers will explore topics such as: (a) Definition and requirements: what is the new EU ABS Regulation and its provisions? (b) International context, background and rationale, and (c) Future steps: implementing the regulation, systems for trusted collections, etc.


    Roundtable on the scope of the EU ABS Regulation

    Panelists in this session will explore the scope of the new EU ABS Regulation and elaborate on what falls under the access and benefit sharing requirements. Topics to be discussed include: (a) common misconceptions, (b) the activities, genetic resource (GR) types, and actors concerned by the Regulation, (c) how the Regulation's requirements should be implemented along the supply chain, (d) exclusions and special cases.


    International mechanisms, user obligations and due diligence: how they work together in practice

    This panel will focus on user obligations under the EU ABS Regulation and how the use of genetic resources will be monitored and verified along the supply chain. It will also discuss how these obligations articulate with national ABS regimes and the international clearing mechanisms.


    Concurrent technical workshops: applying ABS to sourcing and R&D

    Participants can choose to attend one of four workshops (free choice). There are two themes (two workshops on each theme):

    (1) ABS in R&D and sourcing when GRs are used as a main/active ingredient/component of a product, or

    (2) ABS in R&D and sourcing when GRs are used as an accessory ingredient/component of a product.

    During these sessions, they will learn how to apply ABS obligations to specific R&D and sourcing scenarios. Their task will be to devise policy for a hypothetical company. They will explore amongst other things: (a) scope - the activities and genetic resources affected by the regulation, (b) PIC & MAT, (c) document requirements, and (d) transmission obligations. At the end the session one discussant from each workshop will relay their group's findings to the larger group.

    Cocktail reception (19.00-20.30)

      TUESDAY 25 NOVEMBER MORNING (09.00-12.30)

      Tools to facilitate compliance: best practices and trusted collections under Regulation

      European Commission speakers will explain, amongst other things, (a) due diligence requirements, (b) recognition of best practices and trusted collections, and (c) monitoring measures.


      Concurrent technical workshops: commercialization, client transactions and internal collections

      Participants will choose to attend (free choice) one of three workshops:

      (1) Commercialization and transactions with customers and licensees – inside the EU

      (2) Commercialization and transactions with customers and licensees – outside the EU

      (3) Managing internal collections.

      During these sessions, they will learn how to apply ABS obligations in a specific company scenario by working out the policy for a hypothetical company. Each workshop will have a discussant who will relay their findings to the larger group.

      Lunch (12.30-13.45)

      TUESDAY 25 NOVEMBER AFTERNOON (13.45 – 18.00)

      Roundtable on insights, challenges and industry best practices

      During this roundtable, panelists representing different sectors will describe their sectorial challenges and share best practices with the aim of helping other sectors and companies understand how best to implement the new Regulation.


      National implementation and national access regimes: challenges and opportunities

      In this session, panelists from government and business will discuss national implementation of the Regulation in their country e.g. competent authorities, monitoring measures and sanctions, as well as describe the status of their country's access regulations.




      Katie Beckett, Research and Innovation Manager, Phytotrade Africa, UK

      Axel Braun, European and Swiss Patent Attorney, F. Hoffmann - La Roche AG, Switzerland

      Szonja Csörgö, Director IP & Legal Affairs, European Seed Association (ESA), Brussels

      Bruno David, Sourcing and Botany Director, Pôle Actifs Végétaux, Pierre Fabre Research Institute, France

      Philippe Desmeth, WFCC President, Belgian Science Policy Office (BELSPO), Belgium

      Virginie D'Enfert, Vice-President, Economic, Environmental and International Affairs, Fédération des Entreprises de la Beauté (FEBEA), France

      Kathyrn Garforth, Programme Officer, Secretariat of the Convention on Biological Diversity

      Ricardo Gent, Geschäftsführer, German Association of Biotechnology Industries (DIB), Germany

      Anke van den Hurk, Deputy Director of Plantum NL, the Dutch Association for the Plant Reproduction Material Sector, The Netherlands; Chair, ICC Task Force on Access and Benefit Sharing, Paris

      Julian Jackson, ABS and Agricultural Plant Genetic Resources, Department for Environment, Food and Rural Affairs (DEFRA), United Kingdom

      Eva Juul Jensen, Senior Policy Advisor, Biodiversity and Species, Nature Agency, Ministry of Environment, Denmark

      Tonya Kemp, Director of International Trade Policy, Personal Care Products Council, United States

      Alicja Kozlowska, Policy Officer - ABS, Global Sustainability, Trade and Multilateral Agreements, European Commission, Brussels

      Soren Flensted Lassen, Senior Department Manager, Novozymes, Denmark

      Christopher Lyal*, Department of Life Sciences, The Natural History Museum, UK

      Dominic Muyldermans, Senior Legal Consultant, IGO Affairs, Croplife, Brussels

      Hugo Maria Schally, Eco Innovation and Circular Economy, Lead EU Negotiator for the Nagoya Protocol, European Commission, Brussels

      Jasmina Muminovic Susic, Genebank Curator, Monsanto, Spain

      Peter Thomsen, Senior Patent Counsel, IP Policy & Litigation, Novartis International AG, Switzerland

      Annelaure Wittman, Policy Officer, Economic Instruments and Biodiversity, Ministry for Ecology, Sustainable Development and Energy, France

      Daphne Yong d’Herve, Chief Intellectual Property Officer, International Chamber of Commerce (ICC), Paris

      * invited


      Monday 24 November (14.00* - 19.00) - Tuesday 25 November (09.00 - 18.00)

      *Registration will begin at 13.30 on Day 1. There will also be a networking cocktail at the end of Day 1 from 19.00 to 20.30.


      Salons Hoche, 9 avenue Hoche, 75008 Paris, France

      Registration fee

      The registration fee* includes participation in the conference and the implementation simulation workshops, all documentation, a cocktail reception on Monday 24 November, lunch on Tuesday 25 November and coffee breaks. Travel and hotel expenses are not included.

      Please note that invoices for this event are being processed by our partner Xing Events

      *Kindly note that VAT not applicable, article 206-1 of the CGI / TVA non applicable, article 206-1 du CGI .

      Travel and accommodation

      Participants are responsible for making their own travel arrangements and hotel reservations. A list of hotels in Paris, with which ICC has negotiated preferential room rates will be sent to you once your registration has been confirmed.

      We are able to dispatch visa invitation letters to support your visa application only after full payment of your registration fees.

      Working language


      Cancellation policy

      50% of the registration fee will be refunded if notice of cancellation is received before 4 November 2014. Cancellations after this date are not refundable. Subject to agreement from ICC prior to the event, the registration may be transferred to another person from the same company or organization at no extra charge. Updated registration information will be required.

      Please note that ICC reserves the right to cancel this event or to make minor alterations to the content and timing of the programme or to the identity of the speakers. In the unlikely event of cancellation, delegates will be offered a full refund. ICC will not, however, be held responsible for any related expense incurred by the participant.


      The photos and audiovisual recordings taken at this event may be used and published by ICC, its subsidiaries or affiliates, for informational or promotional purposes in printed materials or online, including on ICC websites and in social media. Participation in the event implies agreement to such use of photos or audiovisual recordings in which the participant may appear unless ICC receives written notification to the contrary.

      Programme and logistics: Jennie Irving, Event Manager, Department of Policy and Business Practices, Email: Jennie Irving, Tel: +33 1 49 53 30 78

      Registration and payment issues: Xing Events, Sales Administrator, Email:

      Sponsorship: Luz Rodriguez, Global Partnerships Manager, Email Luz Rodriguez, Tel: + 33 1 49 53 28 42

      This event offers you an unrivalled opportunity to build worldwide partnerships. Partnering will get you visibility with the major decision makers in global business and/or within the international ABS network. For further information, please contact

      Download Document(s)

      Event registration fees

      Participant €590

      VAT not applicable, article 206-1 of the CGI